Deepa Camenga, MD, MHS, FAAP
Cards
About
Titles
Associate Professor of Emergency Medicine
Associate Director of Pediatric Programs, Yale Program in Addiction Medicine; Associate Professor on Term, Chronic Disease Epidemiology
Biography
Dr. Deepa Camenga is an Associate Professor of Emergency Medicine, Section of Research at Yale. She is a Physician-Scientist who is board certified in pediatrics and addiction medicine with expertise in adolescent addiction. Her research aims to improve the identification and treatment of substance use and substance use disorders among youth in pediatric settings. She is also the Associate Director for Pediatric Programs for the Yale Program in Addiction Medicine. In this role, she is one of a very few clinicians in the state that prescribes medication treatment for adolescents with opioid use disorder. She also leads an innovative addiction medicine tele-consult service for local school-based health centers and treats adolescents and young adults at the APT Foundation. In 2017, Dr. Camenga was elected to serve on a national American Academy of Pediatrics Committee on Substance Use and Prevention, tasked with protecting and improving the health and well-being of children and adolescents throughout the country.
Dr. Camenga completed her medical education and residency training at the University of Rochester, NY. Dr. Camenga completed a fellowship in health services research through the Robert Wood Johnson Foundation Clinical Scholars Program at Yale.
Appointments
Emergency Medicine
Associate Professor on TermPrimaryChronic Disease Epidemiology
Associate Professor on TermSecondaryGeneral Pediatrics
Associate Professor on TermSecondary
Other Departments & Organizations
- Center for Brain & Mind Health
- Center for Immersive Technologies
- Chronic Disease Epidemiology
- Developmental Neurocognitive Driving Simulation Research Center (DrivSim Lab)
- Emergency Medicine
- Emergency Medicine York Street Campus Faculty
- Gaither Lab
- General Pediatrics
- Program in Addiction Medicine
- Psychotherapy Development Center
- Tobacco Research in Youth (TRY)
- Yale Center for Health & Learning Games
- Yale Medicine
- Yale School of Public Health
- Yale Tobacco Center of Regulatory Science
- Yale-Drug use, Addiction, and HIV prevention Research Scholars (DAHRS)
Education & Training
- MHS
- Yale School of Medicine, Health Services Research (2012)
- Postdoctoral Fellow
- Yale School of Medicine (2012)
- Chief Resident
- Children's Strong Hospital, Rochester, New York (2009)
- Residency
- University of Rochester Golisano Children Hospital (2008)
- MD
- Univ of Rochester School of Medicine & Dentistry (2005)
- BA
- Yale University (2000)
Research
Overview
Dr. Camenga’s research focuses on reducing the morbidity and mortality associated with adolescent substance use and substance use disorders. Specifically, her work focuses on improving the identification and treatment of drug and tobacco use in healthcare settings. She also is interested in developing and evaluating novel technology-enhanced interventions to reduce drug use in both adolescents and young adults.
Medical Subject Headings (MeSH)
Academic Achievements & Community Involvement
Clinical Care
Overview
Clinical Specialties
Fact Sheets
Opioid Use Disorder
Learn More on Yale MedicineQuit Smoking
Learn More on Yale MedicineSmoking and Cancer
Learn More on Yale Medicine
Board Certifications
Addiction Medicine
- Certification Organization
- AB of Preventive Medicine
- Original Certification Date
- 2018
Pediatrics
- Certification Organization
- AB of Pediatrics
- Latest Certification Date
- 2016
- Original Certification Date
- 2008
Yale Medicine News
News & Links
Media
News
- May 01, 2024Source: PBS
What is cannabinoid hyperemesis syndrome? Here’s what to know, and why experts say it’s on the rise
- March 25, 2024
Contraceptive Access for Adolescents and Young Adults Varies Across Different Demographics
- February 27, 2024Source: WCVB
Mass. General, Yale study: Most pediatricians not prepared to treat teen opioid use
- February 16, 2024Source: WBUR
More kids are dying of drug overdoses. Could pediatricians do more to help?